Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vaxcyte Inc (PCVX)

Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Stock Roundup: MDGL, PCVX Up on Study Data, MRNA Provides Updates

Pipelines updates from Madrigal (MDGL) and Vaxcyte, (PCVX) are the key highlights of the biotech sector.

GSK : 39.95 (-1.36%)
MRK : 125.06 (-0.90%)
MRNA : 103.79 (-0.07%)
MDGL : 232.98 (+0.70%)
PCVX : 62.24 (-0.24%)
Vaxcyte (PCVX) Up on Pneumococcal Conjugate Vaccine Data

Vaxcyte (PCVX) announces positive results from the mid-stage study of its 24-Valent pneumococcal conjugate vaccine candidate, VAX-24, in adults aged 65 and older.

PFE : 25.69 (-0.85%)
NVO : 123.45 (-0.36%)
LGND : 79.92 (+0.19%)
PCVX : 62.24 (-0.24%)
Still 50% Upside To Go, Wall Street Is Getting Vaxcyte Right

When a biotech company delivers chart-busting news, more often follows. In a space that can be like throwing darts, Wall Street has bullseyes on Vaxcyte, Inc.

PCVX : 62.24 (-0.24%)
PFE : 25.69 (-0.85%)
MRK : 125.06 (-0.90%)
Why Investors Are Suddenly Excited About Vaxcyte

Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet.

PCVX : 62.24 (-0.24%)
PFE : 25.69 (-0.85%)
MRNA : 103.79 (-0.07%)
STRO : 3.94 (-4.83%)
MRK : 125.06 (-0.90%)
Why Shares of Vaxcyte Rose 110.7% This Week

The company released early data for a promising pneumonia vaccine.

PFE : 25.69 (-0.85%)
PCVX : 62.24 (-0.24%)
Recent Price Trend in Vaxcyte, Inc. (PCVX) is Your Friend, Here's Why

Vaxcyte, Inc. (PCVX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through...

PCVX : 62.24 (-0.24%)
Vaxcyte, Myovant rise; Dorman, Shift4 Payments fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

DORM : 88.95 (-0.90%)
TSLA : 157.11 (-2.71%)
MYOV : 26.98 (-0.04%)
PCVX : 62.24 (-0.24%)
SCHL : 35.16 (-0.20%)
FOUR : 62.14 (+0.36%)
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody

Incyte (NASDAQ:INCY) today announced that the Company has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on the development...

INCY : 53.22 (-0.39%)
MOLN : 3.91 (-1.01%)
PCVX : 62.24 (-0.24%)
AURA : 7.26 (-3.84%)
CNTA : 11.03 (+2.32%)
Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update

-- Completed Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in...

PCVX : 62.24 (-0.24%)
Vaxcyte (PCVX) Completes Enrollment in Pneumococcal Disease Study

Vaxcyte (PCVX) enrolls the last patient in the phase II portion of phase I/HH study, evaluating VAX-24 for preventing invasive pneumococcal disease and pneumonia in healthy adults.

MRK : 125.06 (-0.90%)
SGEN : 228.74 (-0.07%)
AQST : 3.85 (-2.28%)
PCVX : 62.24 (-0.24%)

Barchart Exclusives

Is Your Ford Stock Dividend Safe Amid the EV Price War?
Ford's dividend yield is currently around 5%, which is over three times the S&P 500's dividend yield. While Ford's yield looks mouthwatering, are the payouts safe amid ongoing EV industry turmoil? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar